BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, February 3, 2026
See today's BioWorld Asia
Home
» Other news to note for Dec. 22, 2020
To read the full story,
subscribe
or
sign in
.
Other news to note for Dec. 22, 2020
Dec. 22, 2020
Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief, including: 9 Meters, Abbvie, Abcellera, Aligos, Allecra, Anges, Aprinoia, Assertio, Astrazeneca, Aurinia, Avery, Biogen, Biomm, Biontech, Bio-Thera Solutions, Biovaxys Technology, Catalent, China Resources Sanjiu Medical & Pharmaceutical, Eisai, Eli Lilly, Emendobio, Enesi, Fosun, Greenwich Lifesciences, GT, Harbour Biomed, Hasten, Heat Biologics, Hitgen, Horizon, I Peace, Immuron, Inovio, Khondrion, Merck, Moderna, Nervgen, Novan, Novavax, Nyrada, Oncoceutics, Open Care, Ose Immunotherapeutics, Otsuka, PDS, Prime, Redhill, Regenacy, Scancell, Sciclone, Shanghai Haini, Shenzhen Hepalink, Shionogi, Takeda, Teijin, Transthera, Y-mabs.
BioWorld Asia
Briefs
Other news to note